Choudhury Debarati, Ghose Anamika, Dhar Chanda Debadatta, Das Talukdar Anupam, Dutta Choudhury Manabendra, Paul Deepjyoti, Maurya Anand Prakash, Chakravarty Atanu, Bhattacharjee Amitabha
Department of Life Science & Bioinformatics, Assam University, Silchar, Assam, India.
Department of Microbiology, Silchar Medical College and Hospital, Silchar, Assam, India.
PLoS One. 2016 Feb 11;11(2):e0149156. doi: 10.1371/journal.pone.0149156. eCollection 2016.
The present study was undertaken to investigate the mutations that are present in mexR gene of multidrug resistant (MDR) isolates of Pseudomonas aeruginosa collected from a tertiary referral hospital of north east India.
76 MDR clinical isolates of P. aeruginosa were obtained from the patients who were admitted to or attended the clinics of Silchar medical college and hospital. They were screened phenotypically for the presence of efflux pump activity by an inhibitor based method. Acquired resistance mechanisms were detected by multiplex PCR. Real time PCR was performed to study the expression of mexA gene of MexAB-OprM efflux pump in isolates with increase efflux pump activity. mexR gene of the isolates with overexpressed MexAB-OprM efflux pump was amplified, sequenced and analysed.
Out of 76 MDR isolates, 24 were found to exhibit efflux pump activity phenotypically against ciprofloxacin and meropenem. Acquired resistance mechanisms were absent in 11 of them and among those isolates, 8 of them overexpressed MexAB-OprM. All the 8 isolates possessed mutation in mexR gene. 11 transversions, 4 transitions, 2 deletion mutations and 2 insertion mutations were found in all the isolates. However, the most significant observation was the formation of a termination codon at 35th position which resulted in the termination of the polypeptide and leads to overexpression of the MexAB-OprM efflux pump.
This study highlighted emergence of a novel mutation which is probably associated with multi drug resistance. Therefore, further investigations and actions are needed to prevent or at least hold back the expansion and emergence of newer mutations in nosocomial pathogens which may compromise future treatment options.
本研究旨在调查从印度东北部一家三级转诊医院收集的多重耐药铜绿假单胞菌分离株mexR基因中存在的突变。
从西尔查尔医学院和医院住院或就诊的患者中获得76株多重耐药铜绿假单胞菌临床分离株。通过基于抑制剂的方法对它们进行表型筛选,以检测外排泵活性的存在。通过多重PCR检测获得性耐药机制。对具有增加外排泵活性的分离株进行实时PCR,以研究MexAB - OprM外排泵的mexA基因表达。对MexAB - OprM外排泵过表达的分离株的mexR基因进行扩增、测序和分析。
在76株多重耐药分离株中,发现24株在表型上对环丙沙星和美罗培南表现出外排泵活性。其中11株不存在获得性耐药机制,在这些分离株中,8株MexAB - OprM过表达。所有8株分离株的mexR基因均存在突变。在所有分离株中发现11个颠换、4个转换、2个缺失突变和2个插入突变。然而,最显著的观察结果是在第35位形成了一个终止密码子,这导致多肽的终止并导致MexAB - OprM外排泵的过表达。
本研究突出了一种可能与多重耐药相关的新突变的出现。因此,需要进一步的调查和行动来预防或至少抑制医院病原体中更新突变的扩展和出现,这可能会损害未来的治疗选择。